Your address will show here +12 34 56 78

JACKSONVILLE, FL – (NewMediaWire) – January 27, 2020 – mCig, Inc. (MCIG), a vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system, today announced the business plan for the nutraceutical joint venture of the Company and Bare Roots, Inc.

BRRX Clinical will operate under two divisions, Consumer Products, and Health Care. The Consumer Products Division will operate much as most other CBD product companies, however, the emphasis will be on products with verifiable efficacy and prescribed dosages. As part of this strategy the company now has three products Registered with an FDA Institutional Review Board (IRB) in Clinical Trials. The first of these, a salve to alleviate the pain from Shingles outbreaks, was announced recently and will be available through a network of independent compounding pharmacies along with two other products also in trials. One of them, a regimen consisting of three packets of a CBD compound ingested daily is targeted at treating liver cirrhosis and fibrosis and is expected to retail for about $400 to $600/month. The last of the three products is a balm targeted at relieving the inflammation from Herpes.

Starting in February, the company will launch its Health Care Division. The core product for this division is a software platform developed over the past 15 years to detect an individual’s predisposition to certain diseases up to three years before symptoms reveal themselves. The platform is a GE/Intel certified program that has been in use for several years. It analyzes blood work, lab results, and genetic information to develop an individual profile that can be used to target that person for certain interventions like a change in diet, supplements or specific exercises.

The launch will start with the BRRX Clinical Subscription Service, a set of services complementing the software platform that will utilize participating clinics and doctor networks to drive consumers to get healthcare before their symptoms require more drastic medical intervention. The plan is for this to be a product marketed to employers, carriers, Physician Networks, and individuals.

According to Dale Hipes, CEO of BRRX Clinical, “We want the focus to be on a holistic approach customized to each client. People can start with a base plan which will have a three-month minimum subscription, and which will develop a blood, genetic, and nutritional profile for each individual. The premium plan is expected to include a week of organic meal service based on an individual’s nutrition plan developed from the initial testing. Members will also have free access to fitness centers, telemedicine services, daily nutraceutical supplements and monthly blood tests in consultation with their physician to identify any bodily changes which could alter their health profile. Additionally, the plan will include catastrophic health insurance and Dental and Vision coverage with required annual checkups.”

The company expects to market the plan through insurance brokers and is conservatively projecting $1 to $2 million in revenue from BRRX Clinical during its first year of operation. This is in addition to the $1.3 million in CBD product orders announced on January 17. New revenue is also expected from the independent pharmacy network as they conduct the aforementioned clinical trials, and from an anticipated CBD cosmetics line to be released later in the year.

Paul Rosenberg, CEO of mCig, Inc., stated: “The clinical subscription service, once launched, could potentially create a significant new revenue stream for mCig. It puts mCig/Bare Roots into a category nothing like any existing CBD company or insurance services provider.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

 

Contact:

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 23, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system today announced that the nutraceutical joint venture of the Company and BRRx Clinical Inc. is set to move forward with an LOI to supply a national independent compounding pharmacy network. BRRX Clinical will begin releasing the CBD enhanced medical foods/topical applications that are in FDA trials. The products are registered with the International Review Board. The first of these offerings will be for the treatment of shingles. The salve will be valuable not only for protocols established but for addressing the pain that accompanies this diagnosis as well. The Researcher, developer, and advisors have hit the mark in this delivery for relief and a trajectory for reversal of this diagnosis.

Dale Hipes, CEO of BRRX Clinical, states, “We are following a very strategic and well-crafted plan by our senior management team. We are looking forward to many great opportunities to affect change, be the standard for the new Healthcare modalities that Hemp-Derived treatments and capabilities bring to the marketplace.”

Paul Rosenberg, CEO of mCig, Inc., added, “Dale completely changed my view on the whole cannabis industry and the steps the Company should take in order to stay ahead of its competitors. In a few weeks, we are going to introduce our revolutionary BRRx Clinical web portal, which will allow the Company to offer some unique products that will change the lives of millions of people.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

 

Contact: 

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 21, 2020 – mCig, Inc. (OTCQB:MCIG), a vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics, that target the endocannabinoid system, announces today that the company’s subsidiary, BareRoots Rx, is launching the Co-branding deal with the Tucson Sugar Skulls of the IFL as their exclusive CBD sports partner.

Dale Hipes, CEO of BareRoots, says: “This is a great opportunity for BareRoots to help bring CBD to households in the Arizona region and Nationally throughout the US. The Tucson SugarSkulls (an IFL Franchise) brings a captive audience of more than 3.5 million fans nationally, and over 900,000 fans native to the Tucson area. BareRoots Rx,  and the Tucson SugarSkulls IFL Franchise will be launching for the 2020 season a co-branded CBD line of products to sell along-side other SugarSkulls products and gear.”

Paul Rosenberg, CEO of mCig, Inc., continued: “The rise in popularity for CBD products can be attributed to the consumer’s quest for natural-based health and wellness solutions to treat perpetual ailments, including those derived from athletics such as inflammation, and pain. The hemp-derived CBD market has been estimated to reach US$22 billion by 2022 and the impact of cannabinoids on health, and treatment has not gone unnoticed in professional sports.

“We will leverage the Scottsdale Facility to manufacture and distribute a suite of athlete-focused, CBD performance products, including:

• CBD Therapeutic sleep tinctures;

• CBD Pain tinctures;

• CBD-infused Protein drinks

• CBD-infused balms for optimal topical absorption.” 

MCIG/BareRoots Rx will be having a grand opening of their new facility, located at: 9332 N 95th Way St. B109, Scottsdale, AZ, on January 30, 2020, between 4-7 pm.

Clients, staff, and partners are all welcome to come.

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

Contact:

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 17, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics that target the endocannabinoid system, today announced that the company’s CBD consumer division has agreements to commence this quarter.

MCIG Inc. subsidiary, BareRoots Rx Inc., the consumer products division, has entered into an agreement to distribute 10,000 monthly boxes of the COMPANY’S PROPRIETARY CBD-BASED PRODUCTS to select tribal communities. The company anticipates revenue of approximately $1.1 Mil in its first year of operation under the agreement. It also has entered into a white labeling agreement with cannabis company to supply approximately $200,000 of CBD derivative products.

“This is an important milestone for company in securing new contractual revenue,” noted Paul Rosenberg, President and CEO, MCIG Inc. “This is the first of what we believe will be many derivative product sales and manufacturing agreements for our new facility in Scottsdale, Arizona.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also deliver high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

Contact: 

mCig, Inc. 

Paul Rosenberg 

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 13, 2020 – mCig, Inc. (OTCQB: MCIG) today announced that its subsidiary BareRoots has launched a completely redesigned website (www.bareroots-rx.com) and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products. 

Through the recently created consumer-driven website, the Company hopes that it’s visitors, customers, and consumers will find the website much easier to use. The navigation has been designed to be much simple, products become very easy to access, and add to cart and a well educative CBD section has been added to match consumer’s lifestyle. BareRoots’ products are rebranded and carefully tailored to be consumer-friendly and much comfortable for consumers to maximize their effectiveness by incorporating CBD’s into their daily routines.

BareRoots’ CEO Dale Hipes remarked, “We continue to see a large increase in consumer demand for high-quality CBD products as the U.S. hemp-derived CBD industry is expected to hit $22 billion by 2022.” In a swift response, “We chose to upgrade our website and rebrand our products to create an easy relationship whereby our consumers can educate themselves before making a decision on the products that best fit their needs.” 

In line with the company’s vision, mCig, Inc. CEO Paul Rosenberg responded, “As the level of awareness for CBD continues to grow, it is our top priority to make sure consumers are well informed and educated on all products and fully understand how it’s going to enhance their lifestyle.” Therefore, the rebranded BareRoots’ products not only provide the importance of CBD, but it also provides a comfortable and aesthetically pleasing platform for consumers to use and display in their various homes. 

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. 

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrogenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers. 

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

 

Contact: 

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – December 12, 2019 – mCig, Inc. (OTCQB:MCIG), a vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics that target the endocannabinoid system, and Bareroots RX Inc. are expanding their activities collectively in the production and development of lifestyle improvement and health care enhancing CBD (cannabinoid) based products. “As we look forward to 2020, our focus has shifted to a healthcare and medically driven CBD botanical products. We’re committed to adapting to the changing cannabis market in order to maximize our company’s growth. We’re entering a new phase of our development, by building a new company together with Bareroots Rx Inc., which will immediately position us as one of the most innovative players in the field of cannabinoid research and product development. “A new joint company will be one of first to market scientifically backed nutrigenetic CBD based proprietary botanical result driven products, that is so terribly needed in the industry. Our OTC products are made of proprietary recipes based with CBD and are engineered to help with a wide array of targeted conditions that we feel will change Healthcare as we know it,” said Paul Rosenberg, CEO of mCig, Inc. “These robust new proprietary CBD OTC botanical nutrigenetic products will launch in the next 90 days, through our new joint brand ‘BRRX Clinical’. We are excited to be on the same page and trajectory as mCig and Mr. Rosenberg,” said Mr. Dale Hipes, CEO of BareRoots Rx Inc. Mr. Rosenberg concluded by saying, “We are shooting for the top, as it is our intention to deliver the best in class, best in the industry products to date. Continue to watch for coming announcements as we roll out our aggressive 5-year plan. We will change the industry standard from association in the marijuana industry and smoke shops to the real value of botanical solutions for a toxic and stressed environment. We believe, you will not be disappointed when trying the best in class and best brand offered by mCig and Bareroots RX.” About MCIG Group Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc About BareRoots Rx Inc. The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers. Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact: mCig, Inc. Paul Rosenberg [email protected]
0

JACKSONVILLE, FL – (NewMediaWire) – November 25, 2019 – mCig, Inc. (OTCQB: MCIG), a company focusing on the marketing, sale, and distribution of CBD products, is pleased to announce that it has entered into a binding letter of intent (“LOI”) to create a joint venture with Bare Roots Rx LLC., a leading supplier of high quality, organic botanical CBD products. Under terms of this agreement, mCig will own 51% of the joint venture in exchange for marketing support, new sales channels, technical support and much needed equipment. Bare Roots Rx has current revenue of approximately $1M and pending orders for 2020 far in excess of current levels. The new Joint Venture will operate two distinct divisions: health care space and consumer products. These divisions will be supported by a medical and scientific advisory board. HEALTH CARE SPACE Bare Roots RX has an innovative and new approach to healthcare and lifestyle via CBD products utilizing medical knowledge and technology. Through the synergistic harmony of these industries, the guesswork of what someone should take to help improve their lifestyle and what the potency of the products are can be eliminated. Bare Roots RX will be approaching this through medically driven science and scientifically driven software which is checked by primary care physicians and holistic coaches along the way. Dale Hipes, Bare Roots Rx CEO, said, “We can cut down the amount of fraud, ignorance and waste of this vital source of remedy. The best part is we will be gathering the pertinent information for medical validity that no one else has thought how to address or is even concerned with. Through our joint partnership with mCig we will change the face of medically driven cannabinoid research.” CONSUMER PRODUCTS The Consumer Products Division will continue to deliver botanically based cannabidiol products that enhance quality of life. The Company will push its Bare Roots Rx brand above the rest using its ISO-Raw technology, which will enable it to produce a broad-spectrum product affecting the ECS with maximum results. The following products will be available to the market immediately: * Lip balms * Eye and face creams * Tattoo and beard balms * Tinctures * Pain balms Customers can buy these organic, pesticide- and glyphosate-free, non-GMO products at BareRoots-Rx.com. The joint venture with Bare Roots Rx adds a strong team member to the portfolio of mCig companies and will create opportunities for great growth for the company in the CBD product market. “MCIG is focusing all our assets and expertise in creating immediate value for our shareholders,” says Paul Rosenberg, CEO of MCIG Inc. “We believe the CBD industry represents the best opportunities for the Company.” About MCIG Group Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to be the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. employs a world-renowned tech team and has recently expanded its products and services to satisfy its evolving role in cannabis and hemp markets. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc CBD Disclaimer The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice. Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact: mCig, Inc. Paul Rosenberg [email protected]
0

JACKSONVILLE, FL – (NewMediaWire) – October 14, 2019 – mCig, Inc. (OTCQB: MCIG) a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, is pleased to announce today the Company will exhibit at MJBizCon on December 11-13, 2019 in Las Vegas, Nevada. The show will provide the Company with the opportunity to further showcase its products, including the CannaPure Ozone unit and innovative LED commercial lights specifically tailored for the cannabis industry. The MJBizCon show is a unique chance for the Company to network with industry executives, learn more about trends in the marketplace, and connect with companies that have similar goals. “We see this conference as an opportunity to increase awareness around MCIG and the CannaPure Ozone Unit, developed in partnership with industry ozone leader Purequest Technology’s. As the cannabis industry becomes more compliant with standard food and pharmaceutical practices our line of ozone solutions will become the standard in every facility in the world,” said Alex Levitsky , CEO of Cannabiz Supply, wholly owned subsidiary of MCIG Inc. MJBizCon is an annual three-day event, where cannabis industry professionals network, listen to premier keynote speakers and explore the more than 150 exhibiting businesses. The event brings together many of top-level individuals and businesses that are all working to advance the cannabis industry while increasing its visibility on a global scale. To arrange one-on-one meetings with MCIG representatives at MJBizCon, contact [email protected] About MCIG Group Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. employs a world-renowned tech team and has recently expanded its products and services to satisfy its evolving role in cannabis and hemp markets. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact: mCig, Inc. Paul Rosenberg [email protected]
0

JACKSONVILLE, FL / ACCESSWIRE / October 10, 2019 / MCIG, Inc. (OTC PINK:MCIG) a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, is pleased to announce the following corporate update on a status of filing Form 10K for the year ended April 20, 2019 and the first quarter 10Q for the quarter ending July 31, 2019. We expect to be current with our filings by the end of the second quarter ending October 31, 2019. In addition, MCIG is updating our shareholders on the status of OBITX trading on the OTC Markets. Mr. Paul Rosenberg, the Company’s Principal Executive Officer, commented: “I am happy to announce we have made good progress with our new auditors in completing the form 10K and 10Q financial filings which will return MCIG’s status to current on OTC Markets. Due to the inability of the former auditor’s to file with the SEC going forward, we have been required to complete a two-year audit, which includes the years ending April 30, 2018 and April 30, 2019. We do not anticipate any major changes that would require a restatement with the prior year’s audit completed by our former auditors.” MCIG issued a special dividend to its shareholders in a new public company, OBITX Inc. through a public registration. OBITX became a public reporting company on December 10, 2018 and is current in all its filings with the SEC. Mr. Rosenberg went on to say, “The process of obtaining a trading symbol from FINRA has taken much longer than anticipated. All the required paperwork has been submitted to FINRA and we are expecting our stock symbol to be issued to OBITX in a timely manner.” About MCIG Group Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to be the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. employs a world-renowned tech team and has recently expanded its products and services to satisfy its evolving role in cannabis and hemp markets. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact: mCig, Inc. Paul Rosenberg [email protected]
0

JACKSONVILLE, FL / ACCESSWIRE / September 17, 2019 / mCig, Inc. (OTC PINK:MCIG) a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, today announced that it has reached mutually agreeable terms to settle lawsuits filed in Nevada. The lawsuits, which were filed in the Eighth Judicial District Court of Nevada for Clarke County and in the United States District Court for the District of Nevada, have been dismissed following agreement to an amicable settlement for all parties involved. Paul Rosenberg, Chairman and Co-CEO of mCig said, “Settlement of these lawsuits will allow all parties to move forward and put all of this behind us. We are grateful for everyone’s cooperation in reaching an agreement that works for all involved. The company is now positioned to focus on positive upcoming announcements”. About mCig, Inc. Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to be the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. employs a world-renowned tech team and has recently expanded its products and services to satisfy its evolving role in cannabis and hemp markets. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: “potential,” “expect”, “look forward,” “believe,” “dedicated,” “building,” or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com Contact: mCig, Inc. Paul Rosenberg [email protected] SOURCE: mCig, Inc.
0